Showing results (1671-1680 of 1,874) with videos related to

Sort By:
Pageof 188
Cancer Chemotherapy and Pharmacology|April 5, 2007
Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II studyJong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2010
Induction treatment with cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma: a phase II studyDeok-Hwan Yang, Yeo-Kyeoung Kim, Sang-Kyun Sohn, et al.
Journal of Korean Medical Science|June 28, 2008
Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosisHo-Jin Shin, Joo Seop Chung, Je-Jung Lee, et al.
Developmental Cell|February 21, 2023
GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasisYu Jin Lee, Kyeong Jin Shin, Hyun-Jun Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2019
EPB41L5 Mediates TGFβ-Induced Metastasis of Gastric CancerMi-Hyeon Jeong, Soo-Yeon Park, Seung-Hyun Lee, et al.
International Journal of Oncology|September 3, 2011
Mitomycin C and doxorubicin elicit conflicting signals by causing accumulation of cyclin E prior to p21WAF1/CIP1 elevation in human hepatocellular carcinoma cellsSun-Young Choi, Yan Nan Shen, Seon Rang Woo, et al.
Experimental & Molecular Medicine|November 1, 2023
PLCγ1 in dopamine neurons critically regulates striatal dopamine release via VMAT2 and synapsin IIIHye Yun Kim, Jieun Lee, Hyun-Jin Kim, et al.
Frontiers in Oncology|December 12, 2022
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatmentJa Min Byun, Ho Young Kim, Seung-Hyun Nam, et al.
Genes|July 29, 2023
Human Endogenous Retrovirus-H-Derived miR-4454 Inhibits the Expression of DNAJB4 and SASH1 in Non-Muscle-Invasive Bladder CancerEun Gyung Park, Du Hyeong Lee, Woo Ryung Kim, et al.
Annals of Hematology|December 20, 2019
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma reportJae-Cheol Jo, Seok Jin Kim, Ho Sup Lee, et al.
Pageof 188